Hearts & Minds Blog

Cost-Effective Innovation

Tim Mayleben

President and Chief Executive Officer

By now you’ve read the headlines about the high cost of the new cholesterol lowering drugs.  We’ve been bombarded with… more

What’s Your “Why”?

Tim Mayleben

President and Chief Executive Officer

This past weekend Esperion participated, for the 15th year, in the American Heart Association’s (AHA) annual Heart Walk to raise… more

Posted In: Tim Mayleben

The Promise of ETC-1002 for Patients at Risk of Cardiovascular Disease

Noah Rosenberg

Chief Medical Officer

Many years ago, as an attending physician in an academic emergency department, I was surprised to see a number of… more

Posted In: Company News

Going with Your Gut

Roger Newton, PhD, FAHA

Executive Chairman and Chief Scientific Officer

Sometimes in science, you have to go with your gut. Years ago, my gut instinct told me that a drug… more